Please assess the completion status of the following clinical trial:

Trial Title: A Text Messaging Program for Smokers in Primary Care

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Adults (≥18 years)~* Smoking status of current smoker in structured field of electronic health record (EHR)~* Language listed as English in EHR~* Massachusetts General Hospital patient, Partners healthcare primary care provider (PCP)~* PCP visit in the past 2 years~* Mobile telephone number listed in EHR~Exclusion Criteria:~* Not a current daily smoker defined as not having smoked ≥100 cigarettes in lifetime or self-report of less than daily current smoking~* Pregnant, planning to become pregnant in the next 3 months, or breastfeeding.~* Past 30-day use of nicotine replacement therapy, bupropion, or varenicline.~* Past 30-day use of Massachusetts state quit-line, QuitWorks or SmokefreeTXT programs~* Prior serious adverse reaction to the nicotine patch or lozenge defined as any reaction that was life-threatening, required hospitalization, or other clinical evaluation~* Ever had an allergy to nicotine patch~* Weight \< 100 pounds~* Unstable coronary disease~* Unstable arrhythmia~* Dementia or active psychosis or schizoaffective disorder affecting ability to consent~* Willing and able to receive and participate with a text message program for up to 12 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Brief advice (Type: ACTIVE_COMPARATOR): Usual care plus brief telephone advice to quit tobacco delivered by a clinical research coordinator who underwent Tobacco Treatment Specialist core training.
- Text messaging (Type: EXPERIMENTAL): Patients randomized to the text messaging program are offered a 12-week text messaging. The text messaging intervention will use content from the National Cancer Institute's SmokeFreeTXT library, content for smokers not ready to quit from SmokeFreeTXT and a pilot feasibility study conducted by the PI, and new messages supporting nicotine replacement medication adherence. The text messaging program will be personalized using subject's first name, the telephone number for the Massachusetts General Hospital (MGH) tobacco cessation counseling services and the Massachusetts state quitline. Smokers receiving the intervention will be sent from 0 and 5 text messages per day.
- Mailed nicotine replacement therapy (Type: EXPERIMENTAL): Subjects randomized to mailed nicotine replacement therapy will be offered a 2 week supply of nicotine replacement therapy mailed to their home address. Daily smokers planning to quit in the next 30 days will be offered nicotine patches (14 or 21 mg patches) and lozenges (2 or 4 mg lozenges) dosed according to package instructions. Non-daily smokers planning to quit will be offered a 2 week allotment of 2 mg lozenges alone. Smokers not planning to quit will be offered one box of lozenges (72 count box of 4 mg or 2 mg lozenges based on time to first cigarette as above per package instructions) to use when they are not smoking during their practice quit attempt.
- Text messaging + mailed NRT (Type: EXPERIMENTAL): Subjects will be offered both the 12 week text message program and 2 weeks of mailed nicotine replacement therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).